Bedell Frazier Investment Counselling’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-4,349
Closed -$1.02M 47
2015
Q4
$1.02M Buy
4,349
+361
+9% +$84.9K 0.51% 32
2015
Q3
$631K Buy
3,988
+203
+5% +$32.1K 0.36% 36
2015
Q2
$1.43M Buy
3,785
+812
+27% +$307K 0.57% 40
2015
Q1
$1.24M Sell
2,973
-1,082
-27% -$452K 0.52% 41
2014
Q4
$1.11M Sell
4,055
-244
-6% -$66.8K 0.54% 40
2014
Q3
$836K Sell
4,299
-75
-2% -$14.6K 0.39% 40
2014
Q2
$1.07M Buy
+4,374
New +$1.07M 0.54% 35